Concepedia
Statistics
Publications
11
Citations
533
H-Index
Active since
2009
Affiliations
Boehringer Ingelheim (Germany)(Current)
University of Bonn
Boehringer Ingelheim (United Kingdom)
Metrum Research Group (United States)
Boehringer Ingelheim (United States)
Silke Retlich is an author at Boehringer Ingelheim (Germany) specializing in pharmacy, pharmacology, and pharmacokinetics.
Publications per year
2009–2017
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase‐4 inhibitor linagliptin <sup>*</sup>
Ulrike Graefe‐Mody, Christian Friedrich, Andreas Port et al. · Diabetes Obesity and Metabolism · 2011 · 185 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Pharmacokinetics of linagliptin in subjects with hepatic impairment
Ulrike Graefe‐Mody, Peter W. Rose, Silke Retlich et al. · British Journal of Clinical Pharmacology · 2012 · 77 citations · Full text
Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg–10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects
Silke Retlich, Vincent Duval, Arne Ring et al. · Clinical Pharmacokinetics · 2010 · 48 citations
Pharmacy, Pharmacokinetics, Pharmacology +10
Impact of Target‐Mediated Drug Disposition on Linagliptin Pharmacokinetics and DPP‐4 Inhibition in Type 2 Diabetic Patients
Silke Retlich, Vincent Duval, Ulrike Graefe‐Mody et al. · The Journal of Clinical Pharmacology · 2010 · 48 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
Binding to dipeptidyl peptidase‐4 determines the disposition of linagliptin (BI 1356) – investigations in DPP‐4 deficient and wildtype rats
Silke Retlich, B. Withopf, Andreas Greischel et al. · Biopharmaceutics & Drug Disposition · 2009 · 47 citations
Pharmacy, Pharmacokinetics, Pharmacology +13
1–5 of 11